chr1-179551119-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_014625.4(NPHS2):​c.*54G>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.619 in 1,607,334 control chromosomes in the GnomAD database, including 309,162 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.61 ( 28879 hom., cov: 31)
Exomes 𝑓: 0.62 ( 280283 hom. )

Consequence

NPHS2
NM_014625.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.952

Publications

11 publications found
Variant links:
Genes affected
NPHS2 (HGNC:13394): (NPHS2 stomatin family member, podocin) This gene encodes a protein that plays a role in the regulation of glomerular permeability. Mutations in this gene cause steroid-resistant nephrotic syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
AXDND1 (HGNC:26564): (axonemal dynein light chain domain containing 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 1-179551119-C-G is Benign according to our data. Variant chr1-179551119-C-G is described in ClinVar as Benign. ClinVar VariationId is 293845.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.628 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014625.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NPHS2
NM_014625.4
MANE Select
c.*54G>C
3_prime_UTR
Exon 8 of 8NP_055440.1Q9NP85-1
AXDND1
NM_144696.6
MANE Select
c.3032-3393C>G
intron
N/ANP_653297.3
NPHS2
NM_001297575.2
c.*54G>C
3_prime_UTR
Exon 7 of 7NP_001284504.1Q9NP85-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NPHS2
ENST00000367615.9
TSL:1 MANE Select
c.*54G>C
3_prime_UTR
Exon 8 of 8ENSP00000356587.4Q9NP85-1
NPHS2
ENST00000367616.4
TSL:1
c.*54G>C
3_prime_UTR
Exon 7 of 7ENSP00000356588.4Q9NP85-2
AXDND1
ENST00000367618.8
TSL:1 MANE Select
c.3032-3393C>G
intron
N/AENSP00000356590.3Q5T1B0-1

Frequencies

GnomAD3 genomes
AF:
0.615
AC:
93387
AN:
151920
Hom.:
28851
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.604
Gnomad AMI
AF:
0.647
Gnomad AMR
AF:
0.638
Gnomad ASJ
AF:
0.640
Gnomad EAS
AF:
0.468
Gnomad SAS
AF:
0.591
Gnomad FIN
AF:
0.620
Gnomad MID
AF:
0.604
Gnomad NFE
AF:
0.626
Gnomad OTH
AF:
0.608
GnomAD4 exome
AF:
0.620
AC:
901687
AN:
1455296
Hom.:
280283
Cov.:
30
AF XY:
0.620
AC XY:
448858
AN XY:
724316
show subpopulations
African (AFR)
AF:
0.601
AC:
20049
AN:
33370
American (AMR)
AF:
0.664
AC:
29640
AN:
44646
Ashkenazi Jewish (ASJ)
AF:
0.659
AC:
17193
AN:
26094
East Asian (EAS)
AF:
0.507
AC:
20098
AN:
39648
South Asian (SAS)
AF:
0.602
AC:
51736
AN:
85910
European-Finnish (FIN)
AF:
0.624
AC:
32612
AN:
52254
Middle Eastern (MID)
AF:
0.654
AC:
3754
AN:
5740
European-Non Finnish (NFE)
AF:
0.622
AC:
689339
AN:
1107446
Other (OTH)
AF:
0.619
AC:
37266
AN:
60188
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
19194
38389
57583
76778
95972
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18380
36760
55140
73520
91900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.615
AC:
93471
AN:
152038
Hom.:
28879
Cov.:
31
AF XY:
0.613
AC XY:
45580
AN XY:
74302
show subpopulations
African (AFR)
AF:
0.604
AC:
25028
AN:
41452
American (AMR)
AF:
0.639
AC:
9763
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.640
AC:
2221
AN:
3470
East Asian (EAS)
AF:
0.468
AC:
2418
AN:
5162
South Asian (SAS)
AF:
0.591
AC:
2846
AN:
4814
European-Finnish (FIN)
AF:
0.620
AC:
6560
AN:
10574
Middle Eastern (MID)
AF:
0.609
AC:
179
AN:
294
European-Non Finnish (NFE)
AF:
0.626
AC:
42582
AN:
67970
Other (OTH)
AF:
0.609
AC:
1284
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1838
3676
5515
7353
9191
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
772
1544
2316
3088
3860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.509
Hom.:
1425
Bravo
AF:
0.617

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Nephrotic syndrome, type 2 (2)
-
-
2
not provided (2)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
4.2
DANN
Benign
0.44
PhyloP100
0.95
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1410591; hg19: chr1-179520254; COSMIC: COSV62634863; COSMIC: COSV62634863; API